Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126033061 | 12603306 | 1 | I | 20151212 | 20151214 | 20160728 | 20160728 | EXP | AU-CELGENEUS-AUS-2015123462 | CELGENE | 71.18 | YR | F | Y | 93.00000 | KG | 20160728 | OT | AU | AU |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126033061 | 12603306 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 55974 | 125 | MG/M**2 | INJECTION FOR INFUSION | ||||||
126033061 | 12603306 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 55974 | 195 | MG | INJECTION FOR INFUSION | ||||||
126033061 | 12603306 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 0 | 1000 | MG/M**2 | UNKNOWN | ||||||
126033061 | 12603306 | 4 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 0 | 1568 | MG | UNKNOWN | ||||||
126033061 | 12603306 | 5 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Oral | 0 | 1 | MG | UNKNOWN | QD | |||||||
126033061 | 12603306 | 6 | C | pantoprazole | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 40 | MG | UNKNOWN | QD | |||||||
126033061 | 12603306 | 7 | C | salbutamol | ALBUTEROL | 1 | Unknown | PUFF | 0 | INHALANT | QID | ||||||||
126033061 | 12603306 | 8 | C | XALATAN | LATANOPROST | 1 | Unknown | DVEP | 0 | UNKNOWN | QD | ||||||||
126033061 | 12603306 | 9 | C | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Oral | UNITS | 0 | UNKNOWN | TID | ||||||||
126033061 | 12603306 | 10 | C | lercanidipine | LERCANIDIPINE | 1 | Oral | 1 MILLIGRAM | 0 | 20 | MG | UNKNOWN | QD | ||||||
126033061 | 12603306 | 11 | C | LYRICA | PREGABALIN | 1 | Oral | 40 MILLIGRAM | 0 | 75 | MG | UNKNOWN | QD | ||||||
126033061 | 12603306 | 12 | C | olmetec | OLMESARTAN MEDOXOMIL | 1 | Oral | 8 | 0 | 40 | MG | UNKNOWN | QD | ||||||
126033061 | 12603306 | 13 | C | PANADOL | ACETAMINOPHEN | 1 | Oral | 1 | 0 | 665 | MG | UNKNOWN | TID | ||||||
126033061 | 12603306 | 14 | C | NOVORAPID | INSULIN ASPART | 1 | Subcutaneous | 75000 | 0 | UNKNOWN | TID | ||||||||
126033061 | 12603306 | 15 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 100 | MG | UNKNOWN | QD | |||||||
126033061 | 12603306 | 16 | C | ferrous forte | 2 | Oral | 20 MILLIGRAM | 0 | 310 | MG | UNKNOWN | QD | |||||||
126033061 | 12603306 | 17 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 75 MILLIGRAM | 0 | 40 | MG | UNKNOWN | QD | ||||||
126033061 | 12603306 | 18 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 100 MILLIGRAM | 0 | UNKNOWN | QD | ||||||||
126033061 | 12603306 | 19 | C | hydroxychloroquine | HYDROXYCHLOROQUINE | 1 | Oral | 40 MILLIGRAM | 0 | 200 | MG | UNKNOWN | QD | ||||||
126033061 | 12603306 | 20 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | UNITS | 0 | UNKNOWN | QD | ||||||||
126033061 | 12603306 | 21 | C | folinic acid | LEUCOVORIN | 1 | Unknown | 30 | 0 | UNKNOWN | |||||||||
126033061 | 12603306 | 22 | C | paracetamol | ACETAMINOPHEN | 1 | Unknown | 310 MILLIGRAM | 0 | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126033061 | 12603306 | 1 | Adenocarcinoma pancreas |
126033061 | 12603306 | 3 | Adenocarcinoma pancreas |
126033061 | 12603306 | 5 | Polymyalgia rheumatica |
126033061 | 12603306 | 6 | Gastrooesophageal reflux disease |
126033061 | 12603306 | 7 | Asthma |
126033061 | 12603306 | 8 | Intraocular pressure increased |
126033061 | 12603306 | 9 | Pancreatic insufficiency |
126033061 | 12603306 | 10 | Hypertension |
126033061 | 12603306 | 11 | Pain |
126033061 | 12603306 | 12 | Hypertension |
126033061 | 12603306 | 13 | Pain |
126033061 | 12603306 | 14 | Type 2 diabetes mellitus |
126033061 | 12603306 | 15 | Cardiovascular event prophylaxis |
126033061 | 12603306 | 16 | Iron deficiency |
126033061 | 12603306 | 17 | Fluid retention |
126033061 | 12603306 | 19 | Polymyalgia rheumatica |
126033061 | 12603306 | 20 | Type 2 diabetes mellitus |
126033061 | 12603306 | 21 | Iron deficiency |
126033061 | 12603306 | 22 | Pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126033061 | 12603306 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126033061 | 12603306 | Anaemia | |
126033061 | 12603306 | Cholangitis | |
126033061 | 12603306 | Febrile neutropenia | |
126033061 | 12603306 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126033061 | 12603306 | 1 | 20151202 | 20151216 | 0 | |
126033061 | 12603306 | 2 | 20151230 | 0 | ||
126033061 | 12603306 | 3 | 20151202 | 20151216 | 0 | |
126033061 | 12603306 | 4 | 20151230 | 0 | ||
126033061 | 12603306 | 5 | 2015 | 20151129 | 0 | |
126033061 | 12603306 | 6 | 201509 | 0 | ||
126033061 | 12603306 | 8 | 2012 | 0 | ||
126033061 | 12603306 | 9 | 201509 | 0 | ||
126033061 | 12603306 | 10 | 201509 | 0 | ||
126033061 | 12603306 | 11 | 201509 | 0 | ||
126033061 | 12603306 | 12 | 200501 | 0 | ||
126033061 | 12603306 | 13 | 200501 | 0 | ||
126033061 | 12603306 | 14 | 201509 | 0 | ||
126033061 | 12603306 | 15 | 200001 | 0 | ||
126033061 | 12603306 | 16 | 201001 | 0 | ||
126033061 | 12603306 | 17 | 200001 | 0 | ||
126033061 | 12603306 | 18 | 201001 | 0 | ||
126033061 | 12603306 | 19 | 201403 | 0 | ||
126033061 | 12603306 | 20 | 201509 | 0 | ||
126033061 | 12603306 | 21 | 201001 | 0 | ||
126033061 | 12603306 | 22 | 200501 | 0 |